Top Story

Answer to common clinical question may predict risk for death

October 5, 2015

Clinician use of “The Surprise Question” may better identify patients at a high risk for death within 1 year than other clinical factors such as cancer stage, patient age and time from diagnosis, according to research presented at the Palliative Care in Oncology Symposium.

“The Surprise Question” (SQ) — “Would you be surprised if this patient died within the next year?” — has been in use since the 1990s, according to study background. However, limited evidence exists as to its utility in the cancer treatment arena.

In the Journals

Greater time burden for medical care among minorities, unemployed

October 5, 2015
Time spent at a health care provider’s office, along with travel time to and from the office, was 25% to 28% longer among minority and unemployed patients…
Roy S. Herbst, MD, PhD

Top Takeaways from ASCO: EGFR-mutated non–small cell lung cancer

October 5, 2015
CHICAGO — Two trials presented during an oral abstract session on lung cancer at the ASCO 2015 Annual Meeting represent “major advances” in the…
Jean M. Youngwerth, MD

The language of cancer: ‘Battle words’ can have unintended consequences

October 5, 2015
Words can carry an enormous amount of weight, and they can impact a person more significantly than one might think.For example, the use of certain “battle…
Carlos Rodriguez-Galindo In the Journals

Poor retinoblastoma outcomes associated with racial, socioeconomic factors

October 5, 2015
Significant racial, ethnic and socioeconomic disparities appeared to exist in the care and outcome of pediatric patients with retinoblastoma, according to the results of…
More News Headlines »
Diabetic Eye Disease Consults: Volume 1, Number 1

Updates in Melanoma 2015: Entering a New Therapeutic Era

This activity is supported by an educational grant from Merck & Co., Inc.

The incidence of melanoma, an aggressive disease that accounts for approximately 75% of skin-cancer-related deaths, is…
More »
VIDEO: Targeted combination therapies become touchstone for care in advanced melanoma

VIDEO: Targeted combination therapies become touchstone for care in advanced melanoma

September 30, 2015
The development of new treatments for patients with advanced melanoma in the past decade has been…
More »
Hematology Oncology Case Consults

The Patient with Invasive Breast Cancer

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with invasive breast cancer.
More »